Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab.
Dunn EF; Iida M; Myers RA; Campbell DA; Hintz KA; Armstrong EA; Li C; Wheeler DL; Oncogene, 2011, vol. 30, issue 5, p 561, ISSN 14765594. ISBN 14765594.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef